Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synovial biomarker levels after platelet-rich plasma injection for knee osteoarthritis
TCTR20220519005Completed
- Sponsor
- The Biologics for Knee Osteoarthritis Research Unit and The Thailand Science Research and Innovation Fund Chulalongkorn University
- Start
- Jul 2020
- Countries
- 1
01
Overview
Open-label, single-arm trial of platelet-rich plasma in knee osteoarthritis (OA), sponsored by The Biologics for Knee Osteoarthritis Research Unit and The Thailand Science Research and Innovation Fund Chulalongkorn University. Primary endpoint: Change in synovial biomarker levels. Started Jul 2020; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on TCTR20220519005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220519005.